Mediolanum International Funds’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.1M Sell
41,323
-1,542
-4% -$865K 0.19% 126
2026
Q1
$23.9M Buy
42,865
+7,734
+22% +$4.96M 0.25% 98
2025
Q4
$24M Sell
35,131
-3,630
-9% -$2.47M 0.24% 102
2025
Q3
$24.4M Buy
38,761
+4,909
+15% +$2.98M 0.26% 86
2025
Q2
$18M Sell
33,852
-1,915
-5% -$916K 0.22% 117
2025
Q1
$14.9M Sell
35,767
-3,703
-9% -$1.61M 0.21% 120
2024
Q4
$16.3M Buy
39,470
+12,201
+45% +$5.35M 0.21% 109
2024
Q3
$13.9M Buy
27,269
+9,388
+53% +$4.56M 0.19% 119
2024
Q2
$8.25M Sell
17,881
-823
-4% -$413K 0.13% 153
2024
Q1
$10.1M Buy
+18,704
New +$10.2M 0.16% 147

Other funds holding IDXX

Mediolanum International Funds's IDXX Position: Q2 2026 in Review

Mediolanum International Funds reduced its Idexx Laboratories (IDXX) stake by 3.6% in Q2 2026, selling an estimated $865K and leaving 41,323 shares worth $22.1M. The position accounts for 0.19% of the portfolio, ranked #126.

Mediolanum International Funds first reported a position in IDXX in Q1 2024 and has held it in 10 quarters since. The position peaked at $24.4M in Q3 2025. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Mediolanum International Funds held 41,323 shares of Idexx Laboratories worth $22.1M as of Q2 2026.
  • Mediolanum International Funds sold 1,542 Idexx Laboratories shares in Q2 2026, an estimated $865K.
  • Idexx Laboratories made up 0.19% of Mediolanum International Funds's portfolio in Q2 2026, its #126 holding.
  • Mediolanum International Funds first reported a position in Idexx Laboratories in Q1 2024 and has held it in 10 quarters since.
  • Mediolanum International Funds's Idexx Laboratories position peaked at $24.4M in Q3 2025.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Mediolanum International Funds's 13F filing for Q2 2026, filed 23 Jul 2026.